3rov
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | + | [[Image:3rov.jpg|left|200px]] | |
- | The | + | <!-- |
+ | The line below this paragraph, containing "STRUCTURE_3rov", creates the "Structure Box" on the page. | ||
+ | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
+ | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
+ | or leave the SCENE parameter empty for the default display. | ||
+ | --> | ||
+ | {{STRUCTURE_3rov| PDB=3rov | SCENE= }} | ||
- | + | ===Insulin's biosynthesis and activity have opposing structural requirements: a new factor in neonatal diabetes mellitus=== | |
- | + | ||
+ | ==About this Structure== | ||
+ | [[3rov]] is a 12 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3ROV OCA]. | ||
+ | [[Category: Arvan, P.]] | ||
+ | [[Category: Brange, J.]] | ||
+ | [[Category: Dodson, E J.]] | ||
+ | [[Category: Dodson, G G.]] | ||
+ | [[Category: Hu, S Q.]] | ||
+ | [[Category: Hua, Q X.]] | ||
+ | [[Category: Huang, K.]] | ||
+ | [[Category: Jia, W H.]] | ||
+ | [[Category: Katsoyannis, P G.]] | ||
+ | [[Category: Liu, M.]] | ||
+ | [[Category: Nakagawa, S H.]] | ||
+ | [[Category: Turkenburg, M.]] | ||
+ | [[Category: Wan, Z L.]] | ||
+ | [[Category: Wang, S H.]] | ||
+ | [[Category: Weiss, M A.]] | ||
+ | [[Category: Whittaker, J.]] | ||
+ | [[Category: Whittingham, J.]] | ||
+ | [[Category: Xu, B.]] | ||
+ | [[Category: Global health]] | ||
+ | [[Category: Hormone]] | ||
+ | [[Category: Insulin fibrillation]] | ||
+ | [[Category: Long-acting insulin analog]] | ||
+ | [[Category: Receptor binding protein engineering]] | ||
+ | [[Category: Stabilizing]] | ||
+ | [[Category: Zinc-binding site]] |
Revision as of 19:23, 2 May 2012
Insulin's biosynthesis and activity have opposing structural requirements: a new factor in neonatal diabetes mellitus
About this Structure
3rov is a 12 chain structure. Full crystallographic information is available from OCA.
Categories: Arvan, P. | Brange, J. | Dodson, E J. | Dodson, G G. | Hu, S Q. | Hua, Q X. | Huang, K. | Jia, W H. | Katsoyannis, P G. | Liu, M. | Nakagawa, S H. | Turkenburg, M. | Wan, Z L. | Wang, S H. | Weiss, M A. | Whittaker, J. | Whittingham, J. | Xu, B. | Global health | Hormone | Insulin fibrillation | Long-acting insulin analog | Receptor binding protein engineering | Stabilizing | Zinc-binding site